| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Nabilah I Chowdhury, Gary Remington, James L Kenned. Genetics of antipsychotic-induced side effects and agranulocytosis. Current psychiatry reports. vol 13. issue 2. 2011-08-11. PMID:21336863. |
clozapine itself has a unique position among antipsychotic medications, representing the treatment of choice in refractory schizophrenia. |
2011-08-11 |
2023-08-12 |
Not clear |
| Danilo Rocha de Jesus, Alexei Gil, Leonardo Barbosa, Maria Inês Lobato, Pedro Vieira da Silva Magalhães, Gabriela Pereira de Souza Favalli, Marco Antonio Marcolin, Zafiris Jeffrey Daskalakis, Paulo da Silva Belmonte-de-Abre. A pilot double-blind sham-controlled trial of repetitive transcranial magnetic stimulation for patients with refractory schizophrenia treated with clozapine. Psychiatry research. vol 188. issue 2. 2011-08-09. PMID:21186062. |
a pilot double-blind sham-controlled trial of repetitive transcranial magnetic stimulation for patients with refractory schizophrenia treated with clozapine. |
2011-08-09 |
2023-08-12 |
Not clear |
| Danilo Rocha de Jesus, Alexei Gil, Leonardo Barbosa, Maria Inês Lobato, Pedro Vieira da Silva Magalhães, Gabriela Pereira de Souza Favalli, Marco Antonio Marcolin, Zafiris Jeffrey Daskalakis, Paulo da Silva Belmonte-de-Abre. A pilot double-blind sham-controlled trial of repetitive transcranial magnetic stimulation for patients with refractory schizophrenia treated with clozapine. Psychiatry research. vol 188. issue 2. 2011-08-09. PMID:21186062. |
this study aimed to investigate the effects of active compared with sham 1-hz repetitive transcranial magnetic stimulation (rtms) applied to the left temporal-parietal cortex in patients with schizophrenia treated with clozapine. |
2011-08-09 |
2023-08-12 |
Not clear |
| Danilo Rocha de Jesus, Alexei Gil, Leonardo Barbosa, Maria Inês Lobato, Pedro Vieira da Silva Magalhães, Gabriela Pereira de Souza Favalli, Marco Antonio Marcolin, Zafiris Jeffrey Daskalakis, Paulo da Silva Belmonte-de-Abre. A pilot double-blind sham-controlled trial of repetitive transcranial magnetic stimulation for patients with refractory schizophrenia treated with clozapine. Psychiatry research. vol 188. issue 2. 2011-08-09. PMID:21186062. |
seventeen right-handed patients with refractory schizophrenia experiencing auditory verbal hallucinations and treated with clozapine were randomly allocated to receive either active rtms or sham stimulation. |
2011-08-09 |
2023-08-12 |
Not clear |
| Elaine Weiner, Robert R Conley, M Patricia Ball, Stephanie Feldman, James M Gold, Deanna L Kelly, Ikwunga Wonodi, Robert P McMahon, Robert W Buchana. Adjunctive risperidone for partially responsive people with schizophrenia treated with clozapine. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. vol 35. issue 11. 2011-08-08. PMID:20664583. |
adjunctive risperidone for partially responsive people with schizophrenia treated with clozapine. |
2011-08-08 |
2023-08-12 |
human |
| Ching-Hua Lin, Chao-Chan Kuo, Li-Shiu Chou, Yeng-Hung Chen, Cheng-Chung Chen, Kuo-Hao Huang, Hsien-Yuan Lan. A randomized, double-blind comparison of risperidone versus low-dose risperidone plus low-dose haloperidol in treating schizophrenia. Journal of clinical psychopharmacology. vol 30. issue 5. 2011-08-08. PMID:20814315. |
monotherapy is recommended for schizophrenia treatment, but the risk-benefit issue of antipsychotic drug combination (except for clozapine) remains unclear. |
2011-08-08 |
2023-08-12 |
Not clear |
| Stefan Löffler, Ansgar Klimke, Ralf Kronenwett, Guido Kobbe, Rainer Haas, Karin Fehse. Clozapine mobilizes CD34+ hematopoietic stem and progenitor cells and increases plasma concentration of interleukin 6 in patients with schizophrenia. Journal of clinical psychopharmacology. vol 30. issue 5. 2011-08-08. PMID:20814329. |
clozapine mobilizes cd34+ hematopoietic stem and progenitor cells and increases plasma concentration of interleukin 6 in patients with schizophrenia. |
2011-08-08 |
2023-08-12 |
Not clear |
| Stefan Löffler, Ansgar Klimke, Ralf Kronenwett, Guido Kobbe, Rainer Haas, Karin Fehse. Clozapine mobilizes CD34+ hematopoietic stem and progenitor cells and increases plasma concentration of interleukin 6 in patients with schizophrenia. Journal of clinical psychopharmacology. vol 30. issue 5. 2011-08-08. PMID:20814329. |
the blood of 8 european patients with schizophrenia without manifest comorbidity was studied whether the classical atypical antipsychotic drug clozapine altered the amount of circulating cd34(+) hematopoietic cells. |
2011-08-08 |
2023-08-12 |
Not clear |
| Sussan Ghassabian, Manoranjenni Chetty, Bruce N Tattam, John Glen, Jeannie Rahme, Zvijezdana Stankovic, Iqbal Ramzan, Michael Murray, Andrew J McLachla. The participation of cytochrome P450 3A4 in clozapine biotransformation is detected in people with schizophrenia by high-throughput in vivo phenotyping. Journal of clinical psychopharmacology. vol 30. issue 5. 2011-08-08. PMID:20841961. |
the participation of cytochrome p450 3a4 in clozapine biotransformation is detected in people with schizophrenia by high-throughput in vivo phenotyping. |
2011-08-08 |
2023-08-12 |
Not clear |
| Daniel Martins-de-Souza, Maria Lebar, Christoph W Turc. Proteome analyses of cultured astrocytes treated with MK-801 and clozapine: similarities with schizophrenia. European archives of psychiatry and clinical neuroscience. vol 261. issue 3. 2011-07-29. PMID:21088845. |
proteome analyses of cultured astrocytes treated with mk-801 and clozapine: similarities with schizophrenia. |
2011-07-29 |
2023-08-12 |
human |
| John Kasckow, Kandi Felmet, Sidney Zisoo. Managing suicide risk in patients with schizophrenia. CNS drugs. vol 25. issue 2. 2011-07-29. PMID:21254789. |
although there is at least modest evidence suggesting that antipsychotic medications protect against suicidal risk, the evidence appears to be most favourable for second-generation antipsychotics, particularly clozapine, which is the only medication approved by the us fda for preventing suicide in patients with schizophrenia. |
2011-07-29 |
2023-08-12 |
Not clear |
| Adam C Trip. Nonfatal pulmonary embolus associated with clozapine treatment: a case series. General hospital psychiatry. vol 33. issue 1. 2011-07-25. PMID:21353146. |
clozapine is a tricyclic dibenzodiazepine efficacious in the management of treatment-resistant chronic schizophrenia. |
2011-07-25 |
2023-08-12 |
Not clear |
| Aygün Ertuğrul, Hatice Ozdemir, Atay Vural, Turgay Dalkara, Herbert Y Meltzer, Esen Sak. The influence of N-desmethylclozapine and clozapine on recognition memory and BDNF expression in hippocampus. Brain research bulletin. vol 84. issue 2. 2011-07-22. PMID:21134422. |
clozapine, which is the most effective treatment option for treatment-refractory schizophrenia, has been reported to have both positive and negative effects on specific cognitive symptoms in patients with schizophrenia and in animal models of cognition. |
2011-07-22 |
2023-08-12 |
rat |
| Aygün Ertuğrul, Hatice Ozdemir, Atay Vural, Turgay Dalkara, Herbert Y Meltzer, Esen Sak. The influence of N-desmethylclozapine and clozapine on recognition memory and BDNF expression in hippocampus. Brain research bulletin. vol 84. issue 2. 2011-07-22. PMID:21134422. |
the aims of this study were to investigate the change in short and long term memory as assessed by the novel object recognition (nor) test and bdnf expression in hippocampus produced by an acute hypoglutamatergic model of memory impairment in schizophrenia induced by administration of the nmda receptor non-competitive antagonist, mk-801 and the ability of clozapine and ndmc to prevent the deleterious effects of mk-801. |
2011-07-22 |
2023-08-12 |
rat |
| Lun Yang, Kejian Wang, Jian Chen, Anil G Jegga, Heng Luo, Leming Shi, Chunling Wan, Xizhi Guo, Shengying Qin, Guang He, Guoyin Feng, Lin H. Exploring off-targets and off-systems for adverse drug reactions via chemical-protein interactome--clozapine-induced agranulocytosis as a case study. PLoS computational biology. vol 7. issue 3. 2011-07-22. PMID:21483481. |
clozapine provides effective treatments for schizophrenia but its usage is limited because of life-threatening agranulocytosis. |
2011-07-22 |
2023-08-12 |
human |
| Maneesh Gupt. Clozapine and co-prescribed psychotropics: a short report. Clinical practice and epidemiology in mental health : CP & EMH. vol 4. 2011-07-14. PMID:18439293. |
clozapine is the drug of choice in treatment resistant schizophrenia. |
2011-07-14 |
2023-08-12 |
Not clear |
| Tammie Lee Demler, Eileen Trigobof. Are clozapine patients at risk for blood dyscrasias with concomitant tamiflu use? Psychiatry (Edgmont (Pa. : Township)). vol 6. issue 11. 2011-07-14. PMID:20049148. |
the objective of this study was to contribute to the evolving literature by evaluating the occurrence of blood dyscrasias with concurrent use of oseltamivir and clozapine (a drug used to treat refractory schizophrenia). |
2011-07-14 |
2023-08-12 |
Not clear |
| Janakiraman Raguraman, K John Vijay Sagar, R Chandrasekara. Effectiveness of clozapine in treatment-resistant schizophrenia. Indian journal of psychiatry. vol 47. issue 2. 2011-07-14. PMID:20711291. |
effectiveness of clozapine in treatment-resistant schizophrenia. |
2011-07-14 |
2023-08-12 |
Not clear |
| Janakiraman Raguraman, K John Vijay Sagar, R Chandrasekara. Effectiveness of clozapine in treatment-resistant schizophrenia. Indian journal of psychiatry. vol 47. issue 2. 2011-07-14. PMID:20711291. |
clozapine has been shown to be superior to chlorpromazine in improving the positive and negative symptoms of schizophrenia. |
2011-07-14 |
2023-08-12 |
Not clear |
| S Kurian, P Tharyan, K S Jaco. Combination of ECT and clozapine in drug-resistant schizophrenia. Indian journal of psychiatry. vol 47. issue 4. 2011-07-14. PMID:20711319. |
combination of ect and clozapine in drug-resistant schizophrenia. |
2011-07-14 |
2023-08-12 |
Not clear |